| |
| |
|
| Insider
Information: |
Aggarwal Gaurav |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
26,970 |
|
|
Indirect Shares
|
3,470,152 |
|
|
| Direct
Value |
$7,466 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,497,122 |
|
|
| Total
Value |
$7,466 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -100.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Hyperion Therapeutics Inc |
HPTX |
Director |
2012-07-31 |
5,000 |
2012-07-31 |
0 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
Chief Business Officer |
2016-01-15 |
20,000 |
|
0 |
Premium* |
|
|
Sierra Oncology Inc |
SRRA |
Director |
2020-01-29 |
0 |
2022-07-01 |
0 |
Premium* |
|
|
Unicycive Therapeutics, Inc. |
UNCY |
Director |
2023-07-11 |
0 |
2023-07-11 |
3,470,152 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2023-12-29 |
1,970 |
2023-12-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GERN |
Geron Corporation |
Director |
– • – |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,970 |
1,970 |
0 |
- |
|
| UNCY |
Unicycive Therapeutics, I... |
Director |
– • – |
2023-07-11 |
4 |
A |
$0.00 |
$0 |
I/I |
3,470,152 |
3,470,152 |
0 |
- |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • – |
2022-07-01 |
4 |
D |
$55.00 |
$150,471,915 |
I/I |
(2,735,853) |
0 |
0 |
- |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • • |
2022-01-31 |
4 |
B |
$27.00 |
$21,600,000 |
I/I |
800,000 |
2,735,853 |
2.25 |
% |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • • |
2022-01-26 |
4 |
OE |
$13.20 |
$6,339,656 |
I/I |
480,277 |
1,935,853 |
0 |
- |
|
| SRRA |
Sierra Oncology Inc |
Director |
– • • |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,455,576 |
1,455,576 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Chief Business Officer |
• – – |
2016-01-15 |
4 |
B |
$2.15 |
$21,500 |
D/D |
10,000 |
20,000 |
2.74 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Chief Business Officer |
• – – |
2015-05-06 |
4 |
B |
$3.62 |
$27,150 |
D/D |
7,500 |
10,000 |
2.74 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Chief Business OfficerOfficer |
• – – |
2014-04-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,500 |
|
- |
|
| HPTX |
Hyperion Therapeutics Inc |
Director |
– • – |
2012-07-31 |
4 |
B |
$10.00 |
$50,000 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
